|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2006-10-25
|
|
pubmed:abstractText |
Pulmonary hypertension (PHT), defined as a pulmonary vascular resistance (PVR) greater than 2.5 Wood units [WU] and(or) transpulmonary gradient (TPG) greater than 12 mm Hg, is a risk factor for mortality in cardiac transplantation due to elevated postoperative right heart failure. Orthotopic heart transplantation is possible if PVR could be reversed below 2.5 WU and TPG below 12 mm Hg. We show the Muenster experience from the last 10 years.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
1552-6259
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
82
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1770-3
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:17062245-Adult,
pubmed-meshheading:17062245-Alprostadil,
pubmed-meshheading:17062245-Antihypertensive Agents,
pubmed-meshheading:17062245-Epoprostenol,
pubmed-meshheading:17062245-Female,
pubmed-meshheading:17062245-Heart Failure,
pubmed-meshheading:17062245-Heart Transplantation,
pubmed-meshheading:17062245-Humans,
pubmed-meshheading:17062245-Hypertension, Pulmonary,
pubmed-meshheading:17062245-Incidence,
pubmed-meshheading:17062245-Male,
pubmed-meshheading:17062245-Middle Aged,
pubmed-meshheading:17062245-Prostaglandins,
pubmed-meshheading:17062245-Retrospective Studies,
pubmed-meshheading:17062245-Risk Factors,
pubmed-meshheading:17062245-Treatment Outcome
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Reversible pulmonary hypertension in heart transplant candidates: to transplant or not to transplant.
|
|
pubmed:affiliation |
Department of Thoracic and Cardiovascular Surgery, University Hospital Muenster, Muenster, Germany. stefan.klotz@ukmuenster.de
|
|
pubmed:publicationType |
Journal Article
|
